Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8086739 | 0.83 | HRH3 (0.36) | — | |
| SCHEMBL28178765 | 0.81 | MAPT (0.32) | MAPT | |
| SCHEMBL28128567 | 0.77 | MAPT (0.33) | MAPT | |
| SCHEMBL3295151 | 0.76 | NAAA (0.32) | — | |
| SCHEMBL11898308 | 0.75 | MAPT (0.33) | MAPT | |
| SCHEMBL28310392 | 0.74 | — | — | |
| SCHEMBL368462 | 0.72 | MAPT (0.31) | MAPT | |
| SCHEMBL1879828 | 0.71 | MAPT (0.32) | MAPT | |
| SCHEMBL28177171 | 0.69 | — | — | |
| SCHEMBL27515319 | 0.67 | NAAA (0.34) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11680343-B2 | Textiles and articles, and processes for making the same | NIKE, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| US-11241826-B2 | Methods of manufacturing articles utilizing foam particles | NIKE, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-20200094473-A1 | METHODS OF MANUFACTURING ARTICLES UTILIZING FOAM PARTICLES | NIKE, INC. | 2020-03-26 | — | — | US | disclosed |
| EP-3603685-A1 | COMPOSITION FOR REPAIRING HARD TISSUE AND KIT FOR REPAIRING HARD TISSUE | Mitsui Chemicals, Inc. (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-9994538-B2 | Latent acids and their use | BASF SE (DE) | 2018-06-12 | — | — | US | disclosed |
| US-20180125165-A1 | TEXTILES AND ARTICLES, AND PROCESSES FOR MAKING THE SAME | NIKE, INC. | 2018-05-10 | — | — | US | disclosed |
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2018-01-11 | — | — | US | disclosed |
| US-8003718-B2 | Oligomeric sterically hindered amines and their use as polymer stabilisers | 3V SIGMA S.P.A. (IT) | 2011-08-23 | — | — | US | disclosed |
| US-20100298473-A1 | OLEFIN ELASTIC RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20090270536-A1 | OLIGOMERIC STERICALLY HINDERED AMINES AND THEIR USE AS POLYMER STABILISERS | 3V SIGMA S.P.A. (IT) | 2009-10-29 | — | — | US | disclosed |
| US-20090269379-A1 | Material Having Antibacterial and Antifungal Properties | CIBA CORP. | 2009-10-29 | — | — | US | disclosed |
| US-7476713-B2 | Crate, an electrical appliance, kitchen ware, a food container, a drink bottle, garden furniture, a washing machine component or an automotive part; resistant against anisotropic shrinkage; homopolymer or copolymer of propylene and metal alcoholate such as zinc glycerolate | CIBA SPECIALTY CHEMICALS CORP. (US) | 2009-01-13 | — | — | US | disclosed |
| US-20070244233-A1 | Adding metal alcoholate such as zinc glycerolate to homopolymer or copolymer of propylene; resistance to anisotropic shrinkage | CIBA SPECIALTY CHEMICALS CORP. | 2007-10-18 | — | — | US | disclosed |
| EP-1472576-A2 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | Ciba SC Holding AG (CH) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003067332-A2 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-08-14 | — | — | WO | disclosed |
| US-5871669-A | MONO-UND BIS-RESORCINYLTRIAZINES USED FOR PHOTOCHEMICAL AND CHEMICAL STABILIZATION OF TEXTILE FIBERS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | LTA, C1S, C9 | MAPT 3464/4885 |
| US-20090270536-A1 | OLIGOMERIC STERICALLY HINDERED AMINES AND THEIR USE AS POLYMER STABILISERS | PCBP1, PARG, PARN | MAPT 209/4885 |
| US-20090269379-A1 | Material Having Antibacterial and Antifungal Properties | POLR1C, NISCH, HSPH1 | MAPT 2872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.